Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.
Schernthaner G, Shehadeh N, Ametov AS, Bazarova AV, Ebrahimi F, Fasching P, Janež A, Kempler P, Konrāde I, Lalić NM, Mankovsky B, Martinka E, Rahelić D, Serafinceanu C, Škrha J, Tankova T, Visockienė Ž. Schernthaner G, et al. Among authors: tankova t. Cardiovasc Diabetol. 2020 Oct 23;19(1):185. doi: 10.1186/s12933-020-01154-w. Cardiovasc Diabetol. 2020. PMID: 33097060 Free PMC article. Review.
Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.
Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, Honka M, Janez A, Krnic M, Lalic N, Martinka E, Rahelic D, Roman G, Tankova T, Várkonyi T, Wolnik B, Zherdova N. Czupryniak L, et al. Among authors: tankova t. Diabetes Technol Ther. 2014 Jul;16(7):460-75. doi: 10.1089/dia.2013.0302. Epub 2014 Apr 9. Diabetes Technol Ther. 2014. PMID: 24716890 Free PMC article. Review.
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG).
Schernthaner G, Lehmann R, Prázný M, Czupryniak L, Ducena K, Fasching P, Janež A, Karasik A, Kempler P, Martinka E, Shestakova MV, Duvnjak LS, Tankova T. Schernthaner G, et al. Among authors: tankova t. Cardiovasc Diabetol. 2017 Oct 23;16(1):137. doi: 10.1186/s12933-017-0622-7. Cardiovasc Diabetol. 2017. PMID: 29061170 Free PMC article. Review.
Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries.
Haluzik M, Kretowski A, Strojek K, Czupryniak L, Janez A, Kempler P, Andel M, Tankova T, Boyanov M, Smircic Duvnjak L, Madacsy L, Tarnowska I, Zychma M, Lalic N. Haluzik M, et al. Among authors: tankova t. Diabetes Ther. 2018 Apr;9(2):727-741. doi: 10.1007/s13300-018-0388-2. Epub 2018 Mar 9. Diabetes Ther. 2018. PMID: 29524189 Free PMC article.
CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle.
Schernthaner G, Wanner C, Jurišić-Eržen D, Guja C, Gumprecht J, Jarek-Martynowa IR, Karasik A, Lalić N, Mankovsky BN, Prázný M, Tankova T, Tsur A, Wascher TC, Wittmann I. Schernthaner G, et al. Among authors: tankova t. Diabetes Res Clin Pract. 2019 Jul;153:30-40. doi: 10.1016/j.diabres.2019.05.013. Epub 2019 May 20. Diabetes Res Clin Pract. 2019. PMID: 31121272 Free article.
SGLT2 inhibitors in T2D and associated comorbidities - differentiating within the class.
Schernthaner G, Drexel H, Moshkovich E, Zilaitiene B, Martinka E, Czupryniak L, Várkonyi T, Janež A, Ducena K, Lalić K, Tankova T, Prázný M, Smirčić Duvnjak L, Sukhareva O, Sourij H. Schernthaner G, et al. Among authors: tankova t. BMC Endocr Disord. 2019 Jun 17;19(1):64. doi: 10.1186/s12902-019-0387-y. BMC Endocr Disord. 2019. PMID: 31208401 Free PMC article.
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review.
Janež A, Guja C, Mitrakou A, Lalic N, Tankova T, Czupryniak L, Tabák AG, Prazny M, Martinka E, Smircic-Duvnjak L. Janež A, et al. Among authors: tankova t. Diabetes Ther. 2020 Feb;11(2):387-409. doi: 10.1007/s13300-019-00743-7. Epub 2020 Jan 4. Diabetes Ther. 2020. PMID: 31902063 Free PMC article. Review.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
128 results